Common and Specific Associations of Anti-SSA/Ro60 and Anti-Ro52/TRIM21 Antibodies in Systemic Lupus Erythematosus
Table 3
Association of anti-SSA/Ro60 and anti-Ro52/TRIM21 with immunological parameters in SLE.
Immunological parameters
141 patients
Anti-SSA/Ro60 ()
Anti-Ro52/TRIM21 ()
%
%
OR (95% CI)
%
OR (95% CI)
Anti-dsDNA
102
72.3
45
75.0
1.93 (0.64–5.79)
26
66.7
0.23 (0.07–0.73)
b
Anti-Sm
15
10.6
7
11.6
1.05 (0.24–4.61)
5
12.8
1.2 (0.25–5.86)
Antiphospholipid
34
24.1
8
13.3
0.33 (0.10–1.08)
5
12.8
0.97 (0.24–3.94)
Anticardiolipin IgG/IgM
20
14.2
4
6.7
0.38 (0.09–1.65)
2
5.1
0.57 (0.08–3.88)
Anti-β 2glicoprotein IgG/IgM
20
14.2
6
10.0
0.52 (0.13–2.08)
4
10.2
1.07 (0.22–5.27)
Lupus anticoagulante
14
9.9
2
3.3
1
2.5
Low complementa
106
75.2
48
80.0
4.61 (1.07–19.97)
c
28
71.8
0.24 (0.05–1.09)
Low C3a
89
63.1
41
68.3
2.44 (0.78–7.64)
24
61.5
0.52 (0.15–1.79)
Low C4a
97
68.8
47
78.3
6.63 (1.63–26.94)
d
27
69.2
0.25 (0.06–1.08)
Anti-SSA/Ro60 and anti-Ro52/TRIM21 analyzed together as independent variables by binary logistic regression analysis adjusted for sex and age (at diagnosis and time of analysis). Other autoantibodies also included as independent variable after selection by forward step procedure: aanti-dsDNA (positive association), b, c, d, and enot statistically analysed.